Leo Marcoff, Konstantinos Koulogiannis, Lilian Aldaia, Anuj Mediratta, Scott M Chadderdon, Moody M Makar, Tobias Friedrich Ruf, Theresa Gößler, Jonathan G Zaroff, Gordon K Leung, Ivy A Ku, Michael Nabauer, Paul A Grayburn, Zuyue Wang, Katie M Hawthorne, Dale E Fowler, Jacob P Dal-Bianco, Mani A Vannan, Carmine Bevilacqua, Massimiliano Meineri, Joerg Ender, Anna Flo Forner, Jyothy J Puthumana, Atizazul Hassan Mansoor, Dustin J Lloyd, Steven J Voskanian, Andrew Ghobrial, Rebecca T Hahn, Feroze Mahmood, Christiane Haeffele, Geraldine Ong, Leonhard Moritz Schneider, Dee Dee Wang, Nishant K Sekaran, Elana Koss, Priti Mehla, Serge Harb, Rhonda Miyasaka, Maria Ivannikova, Terri Stewart-Dehner, Lucas Mitchel, Sasan R Raissi, Daniel Kalbacher, Santanu Biswas, Edwin C Ho, Ythan Goldberg, Robert L Smith, Jörg Hausleiter, D Scott Lim, Linda D Gillam
BACKGROUND: The CLASP IID randomized trial (Edwards PASCAL TrAnScatheter Valve RePair System Pivotal Clinical Trial; NCT03706833) demonstrated the safety and effectiveness of the PASCAL system for mitral transcatheter edge-to-edge repair (M-TEER) in patients at prohibitive surgical risk with significant symptomatic degenerative mitral regurgitation (DMR). OBJECTIVES: This study describes the echocardiographic methods and outcomes from the CLASP IID trial and analyzes baseline variables associated with residual mitral regurgitation (MR) ≤1+...
December 1, 2023: JACC. Cardiovascular Imaging